Connect your AI

OS Therapies OSTX Stock Issued During Period Shares To Investment Advisor

Stock Issued During Period Shares To Investment Advisor at other companies

TTR

Turn Therapeutics Inc. Common StockTTRX

$54.47K—

Opus GeneticsIRD

118.5K+40.6%

Bit DigitalBTBT

$0—

AGNC Investment Corp.AGNC

2.2M+15.8%

EAT

Brinker InternationalEAT

$400K-33.3%

Solidion Technology, Inc.STI

$955.28K+446%

Other financials

Income statement

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept osti:StockIssuedDuringPeriodSharesToInvestmentAdvisor.

The official record: OS Therapies’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's stock issued during period shares to investment advisor.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is OS Therapies's stock issued during period shares to investment advisor?: OS Therapies (OSTX) reported stock issued during period shares to investment advisor of $32.5K in Q4 2024.
What does stock issued during period shares to investment advisor mean?: This represents the value of equity-based compensation or fees paid to investment advisors or financial consultants in the form of company shares. It indicates the use of equity as a non-cash payment method for professional services rendered. Monitoring this helps investors understand the extent of share-based dilution used to preserve cash.